000 01391 a2200361 4500
005 20250513154354.0
264 0 _c19990504
008 199905s 0 0 eng d
022 _a0006-3223
024 7 _a10.1016/s0006-3223(98)00195-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaye, W
245 0 0 _aSerotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.
_h[electronic resource]
260 _bBiological psychiatry
_cNov 1998
300 _a825-38 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnorexia Nervosa
_xdrug therapy
650 0 4 _aAppetite Regulation
_xphysiology
650 0 4 _aBulimia
_xdrug therapy
650 0 4 _aDisease Progression
650 0 4 _aFood-Drug Interactions
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHumans
650 0 4 _aNeural Pathways
_xphysiology
650 0 4 _aNutritional Physiological Phenomena
_xphysiology
650 0 4 _aObsessive Behavior
_xphysiopathology
650 0 4 _aSerotonin
_xphysiology
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xpharmacology
700 1 _aGendall, K
700 1 _aStrober, M
773 0 _tBiological psychiatry
_gvol. 44
_gno. 9
_gp. 825-38
856 4 0 _uhttps://doi.org/10.1016/s0006-3223(98)00195-4
_zAvailable from publisher's website
999 _c9771986
_d9771986